4.5 Article

Multi-perspective quality control of Illumina RNA sequencing data analysis

期刊

BRIEFINGS IN FUNCTIONAL GENOMICS
卷 16, 期 4, 页码 194-204

出版社

OXFORD UNIV PRESS
DOI: 10.1093/bfgp/elw035

关键词

RNA-seq; small RNA-seq; total RNA-seq; quality control; raw data; alignment; gene expression

资金

  1. NIH [P30 CA68485]
  2. National Institutes of Health, National Heart, Lung and Blood Institute [HL128996, HL113039, HL116263]
  3. American Heart Association [CSA2066001]

向作者/读者索取更多资源

Quality control (QC) is a critical step in RNA sequencing (RNA-seq). Yet, it is often ignored or conducted on a limited basis. Here, we present a multi-perspective strategy for QC of RNA-seq experiments. The QC of RNA-seq can be divided into four related stages: (1) RNA quality, (2) raw read data (FASTQ), (3) alignment and (4) gene expression. We illustrate the importance of conducting QC at each stage of an RNA-seq experiment and demonstrate our recommended RNA-seq QC strategy. Furthermore, we discuss the major and often neglected quality issues associated with the three major types of RNA-seq: mRNA, total RNA and small RNA. This RNA-seq QC overview provides comprehensive guidance for researchers who conduct RNA-seq experiments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy

Jing Yang, Shilin Zhao, Jing Wang, Quanhu Sheng, Qi Liu, Yu Shyr

Summary: Cancer-Immu is a comprehensive platform that integrates various omics data and clinical phenotypes to explore immunogenomic connections. It provides easy access to data and helps researchers translate omics datasets into biological insights and clinical applications.

CANCER RESEARCH (2022)

Review Oncology

Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer

Jamie E. Chaft, Yu Shyr, Boris Sepesi, Patrick M. Forde

Summary: Biomarker-informed clinical trials are pushing the treatment of early-stage lung cancer beyond cytotoxic chemotherapy, with the incorporation of targeted and immunotherapies. Adjuvant osimertinib, preoperative chemoimmunotherapy, and adjuvant immunotherapy could improve outcomes for resectable lung cancer patients, and ongoing or planned studies focusing on biomarkers, immunotherapy, and targeted therapy may further enhance survival.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

COVID-19 vaccination and breakthrough infections in patients with cancer

A. L. Schmidt, C. Labaki, C-Y Hsu, Z. Bakouny, N. Balanchivadze, S. A. Berg, S. Blau, A. Daher, T. El Zarif, C. R. Friese, E. A. Griffiths, J. E. Hawley, B. Hayes-Lattin, V Karivedu, T. Latif, B. H. Mavromatis, R. R. McKay, G. Nagaraj, R. H. Nguyen, O. A. Panagiotou, A. J. Portuguese, M. Puc, M. Santos Dutra, B. A. Schroeder, A. Thakkar, E. M. Wulff-Burchfield, S. Mishra, D. Farmakiotis, Yu Shyr, J. L. Warner, T. K. Choueiri

Summary: This study analyzes the clinical features of cancer patients who develop symptomatic COVID-19 after vaccination. It finds that these patients often have comorbidities and can experience severe and even lethal infections. Hematologic malignancy patients are over-represented among the vaccinated cancer patients who develop symptomatic COVID-19. Therefore, while vaccination remains crucial in protecting vulnerable populations, including cancer patients, those who develop breakthrough infections despite full vaccination still face the risk of severe outcomes.

ANNALS OF ONCOLOGY (2022)

Article Oncology

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

Ziad Bakouny, Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih-Yuan Hsu, Saif Alimohamed, Babar Bashir, Stephanie Berg, Mehmet A. Bilen, Daniel Bowles, Cecilia Castellano, Aakash Desai, Arielle Elkrief, Omar E. Eton, Leslie A. Fecher, Daniel Flora, Matthew D. Galsky, Margaret E. Gatti-Mays, Alicia Gesenhues, Michael J. Glover, Dharmesh Gopalakrishnan, Shilpa Gupta, Thorvardur R. Halfdanarson, Brandon Hayes-Lattin, Mohamed Hendawi, Emily Hsu, Clara Hwang, Roman Jandarov, Chinmay Jani, Douglas B. Johnson, Monika Joshi, Hina Khan, Shaheer A. Khan, Natalie Knox, Vadim S. Koshkin, Amit A. Kulkarni, Daniel H. Kwon, Sara Matar, Rana R. McKay, Sanjay Mishra, Feras A. Moria, Amanda Nizam, Nora L. Nock, Taylor K. Nonato, Justin Panasci, Lauren Pomerantz, Andrew J. Portuguese, Destie Provenzano, Matthew Puc, Yuan J. Rao, Terence D. Rhodes, Gregory J. Riely, Jacob J. Ripp, Andrea Rivera, Erika Ruiz-Garcia, Andrew L. Schmidt, Adam J. Schoenfeld, Gary K. Schwartz, Sumit A. Shah, Justin Shaya, Suki Subbiah, Lisa M. Tachiki, Matthew D. Tucker, Melissa Valdez-Reyes, Lisa B. Weissmann, Michael T. Wotman, Elizabeth M. Wulff-Burchfield, Zhuoer Xie, Yuanchu James Yang, Michael A. Thompson, Dimpy P. Shah, Jeremy L. Warner, Yu Shyr, Toni K. Choueiri, Trisha M. Wise-Draper

Summary: This cohort study found that systemic anticancer therapies, especially IO, in the context of baseline immunosuppression, were associated with severe clinical outcomes and the development of cytokine storm in patients with cancer and COVID-19.

JAMA ONCOLOGY (2023)

Letter Cardiac & Cardiovascular Systems

Single-Nuclear RNA Sequencing of Endomyocardial Biopsies Identifies Persistence of Donor-Recipient Chimerism With Distinct Signatures in Severe Cardiac Allograft Vasculopathy

Kaushik Amancherla, Juan Qin, Michelle L. Hulke, Ryan D. Pfeiffer, Vineet Agrawal, Quanhu Sheng, Yaomin Xu, Kelly H. Schlendorf, JoAnn Lindenfeld, Ravi V. Shah, Jane E. Freedman, Nathan R. Tucker, Javid Moslehi

CIRCULATION-HEART FAILURE (2023)

Article Biochemistry & Molecular Biology

How T118M peripheral myelin protein 22 predisposes humans to Charcot-Marie-Tooth disease

Katherine M. Stefanski, Geoffrey C. Li, Justin T. Marinko, Bruce D. Carter, David C. Samuels, Charles R. Sanders

Summary: Cellular and biophysical studies were conducted to investigate the effects of the T118M PMP22 variation leading to CMT disease. It was found that T118M PMP22 reduces surface-trafficked PMP22 without forming toxic intracellular aggregates, explaining the incomplete disease penetrance and mild neuropathy observed in WT/T118M CMT cases. Additionally, a statistically significant association between the T118M mutation and the occurrence of carpal tunnel syndrome was identified.

JOURNAL OF BIOLOGICAL CHEMISTRY (2023)

Article Clinical Neurology

Polygenic Contributions to Chronic Overlapping Pain Conditions in a Large Electronic Health Record Sample

Lori Schirle, David C. Samuels, Annika Faucon, Nancy J. Cox, Stephen Bruehl

Summary: This study employed a genome-wide poly-genic risk score approach to evaluate genetic influences on 8 common chronic overlapping pain conditions. The findings suggest a shared polygenic influence potentially involving central sensitization mechanisms across these conditions. This study provides evidence supporting future research on biomarkers and risk assessment.

JOURNAL OF PAIN (2023)

Article Oncology

Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+Breast Cancer

Eric M. Lander, Katherine C. Rappazzo, Li-Ching Huang, Jiun-Ruey Hu, Heidi Chen, Yu Shyr, Vandana G. Abramson

Summary: This novel study investigates the relationship between HER2 amplification and pathologic complete response (pCR) following neoadjuvant anti-HER2 dual therapy without chemotherapy. The results show a positive association between the HER2/CEP17 FISH ratio and pCR.

ONCOLOGIST (2023)

Article Genetics & Heredity

MitoTrace: A Computational Framework for Analyzing Mitochondrial Variation in Single-Cell RNA Sequencing Data

Mingqiang Wang, Wankun Deng, David C. C. Samuels, Zhongming Zhao, Lukas M. M. Simon

Summary: Genetic variation in the mitochondrial genome is important and related to human diseases. Single-cell RNA sequencing (scRNAseq) has become a popular technique to study transcriptomics at the cellular level. However, the study of mitochondrial variants using scRNAseq data has been limited. In this study, we developed an R package called MitoTrace to analyze mitochondrial genetic variation in scRNAseq data and demonstrated its effectiveness in recovering genetic variants in different datasets.
Article Medicine, Research & Experimental

Characterizing the T Cell Repertoire in the Proximal Airway in Health and Disease

Evan A. Clark, Edward Ryan R. Talatala, Wenda Ye, Ruth J. Davis, Samuel L. Collins, Alexander T. Hillel, Marisol Ramirez-Solano, Quanhu Sheng, Celestine N. Wanjalla, Simon A. Mallal, Alexander Gelbard

Summary: This study found that SGS cases do not have lower diversity in adaptive immune response compared to healthy controls. Interestingly, both in health and disease, the TCR repertoire contains a restricted number of high frequency clonotypes that do not significantly overlap between individuals.

LARYNGOSCOPE (2023)

Article Oncology

Systematic Assessment of Small RNA Profiling in Human Extracellular Vesicles

Jing Wang, Hua-Chang Chen, Quanhu Sheng, T. Renee Dawson, Robert J. Coffey, James G. Patton, Alissa M. Weaver, Yu Shyr, Qi Liu

Summary: Through a systematic assessment of small RNA sequencing, we identified the quality, technical, and potential biological biases introduced by different EV isolation methods and the enrichment of specific small RNA types in EVs. The findings from this study provide guidance for quality control of EV small RNA-seq, selection of EV isolation techniques, and enhance the interpretation of small RNA contents and preferential loading in EVs.

CANCERS (2023)

Article Oncology

Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma

Kristina Fanucci, Mary Jo Pilat, Derek Shyr, Yu Shyr, Scott Boerner, Jing Li, Diane Durecki, Jan Drappatz, Vinay Puduvalli, Frank Scott Lieberman, Javier Gonzalez, Pierre Giglio, S. Percy Ivy, Ranjit S. Bindra, Antonio Omuro, Patricia LoRusso

Summary: A multicenter study evaluated the efficacy of olaparib monotherapy in patients with IDH1/2-mutant gliomas. The study showed that olaparib monotherapy can produce prolonged disease stabilization in patients with grade 2/3 histology, but not in patients with grade 4 histology. This suggests potential clinical benefit of olaparib monotherapy in select populations.

CANCER RESEARCH COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

scDemultiplex: An iterative beta-binomial model-based method for accurate demultiplexing with hashtag oligos

Li-Ching Huang, Lindsey K. Stolze, Hua-Chang Chen, Alexander Gelbard, Yu Shyr, Qi Liu, Quanhu Sheng

Summary: Single-cell sequencing is widely used for studying cellular heterogeneity, and sample multiplexing is an important technique that allows for increased capacity, decreased costs, and minimized batch effects. The crucial step in analyzing multiplexed data is demultiplexing, which assigns cells to individual samples. Accurate demultiplexing is essential to avoid misleading characterization.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2023)

Article Respiratory System

Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors

Emily Pei-Ying Lin, Li-Ching Huang, Jennifer Whisenant, Sally York, Travis Osterman, Jennifer Lewis, Wade Iams, Emily Skotte, Amanda Cass, Chih-Yuan Hsu, Yu Shyr, Leora Horn

Summary: This study shows that influenza vaccination (FV) does not increase toxicity for patients with advanced thoracic cancer on immune checkpoint inhibitors (ICIs) and is associated with a decreased risk of grade 3-5 immune-related adverse events (IRAEs). However, FV does not have a statistically significant impact on survival times.

ERJ OPEN RESEARCH (2022)

暂无数据